C erebral injury may be caused by traumatic brain injury, stroke, and cardiac arrest. Hypercapnia and hypocapnia are avoided in such patients to prevent secondary brain injury.
1 Clinical studies investigating the effects of hypocapnia and hypercapnia on traumatic brain injury and cardiac arrest revealed that hypocapnia and hypercapnia were associated with increased in-hospital mortality. [2] [3] [4] [5] [6] Clinical studies evaluating the effects of arterial partial pressure of carbon dioxide (PCO 2 ) derangements in stroke are very few. [7] [8] [9] Two studies investigated the effect of hypocapnia, with differing results. 7, 8 A retrospective observational study in patients with subarachnoid hemorrhage showed higher mortality with hypocapnia, 8 and a randomized clinical trial with a sample size of 50 patients with pituitary apoplexy reported no difference in mortality when hypocapnia was compared with normocapnia. 7 The study by Westermaier et al 9 in patients with aneurysmal subarachnoid hemorrhage found benefit in outcome with hypercapnia. In addition to PCO 2 , pH level appears to have a significant effect on clinical outcomes in patients with acute cerebral injury. Acidic pH has been shown to have an increased risk of mortality and unfavorable outcomes in patients with severe traumatic brain injury, 10 out-of-hospital cardiac arrest, 11 and ischemic stroke.
12,13
All these studies have mainly focused on the changes in PCO 2 and pH in isolation and have not evaluated the effects of PCO 2 and pH in conjunction. To our knowledge, no study has investigated for differences in outcomes between compensated hypercapnia and hypercapnic acidosis. Given this limited data and lack of evaluation of the outcomes in combination of PCO 2 and pH, we aimed to review the effects of compensated hypercapnia and hypercapnic acidosis during the first 24 hours of intensive care unit (ICU) admission on clinical outcomes in adult mechanically ventilated patients with cerebral injury caused by cardiac arrest, stroke, and traumatic brain injury.
Methods
We conducted a retrospective review of all patients who had cerebral injury and were mechanically ventilated during a 16-year period (January 2000 to December 2015) admitted to 167 ICUs in Australia and New Zealand. Data were collected from the Australian and New Zealand Intensive Care Society Adult Patient Database. The Australian and New Zealand Intensive Care Society Adult Patient Database is a high-quality database run by the Australian and New Zealand Intensive Care Society Center for Outcome and Resource Evaluation. It collates complete patient information that is required to calculate patient severity during the first 24 hours of ICU admission from more than 80% of ICUs across Australia and New Zealand as part of quality assurance and benchmarking process among participating ICUs. Ethics approval was obtained from Monash University research ethics committee. The ethics committee waived informed consent from the patients because the data were gathered as part of routine quality assurance benchmarking process for the participating ICUs.
Adult patients with cerebral injury receiving mechanical ventilation during the first 24 hours of their admission to the ICU were included in the study. Cerebral injury was diagnosed if the patients had admission diagnosis of 1 of 3 diagnostic categories: traumatic brain injury, cardiac arrest, or stroke (including intracerebral hemorrhage, subdural, subarachnoid hemorrhage, and ischemic stroke). For this analysis, we used the arterial blood gas that provided the highest scoring Acute Physiology, Age, Chronic Health Evaluation III subscore and as such is likely to have represented the worst pH/PCO 2 combination in the first 24 hours of ICU admission. Patients were classified into 3 groups based on a combination of arterial pH and arterial carbon dioxide levels: normocapnia (PCO 2 , 35-45 mm Hg) and normal pH (7.35-7.45) (group 1), compensated hypercapnia (normal pH [7.35-7.45 ] with elevated carbon dioxide [PCO 2 >45 mm Hg]) (group 2), and hypercapnic acidosis (PCO 2 >45 mm Hg and pH <7.35) (group 3) during the first 24 hours of ICU stay. Patients with metabolic acidosis, metabolic alkalosis, and respiratory alkalosis were excluded because the focus of the study was to investigate the effects of compensated hypercapnia and hypercapnic acidosis on the outcomes after cerebral injury. Patients in group 1 were considered a reference group to which patients in group 2 and 3 were compared. The primary outcome measure included hospital mortality. Secondary outcome measures included ICU mortality, duration of ICU and hospital stay, and survival to discharge home.
All analysis was performed using SAS, version 9.4 (SAS Institute Inc). Data were initially assessed for normality. Group comparisons were made using χ 2 tests for equal proportion, analysis of variance for normally distributed variables, and Kruskal-Wallis tests otherwise, with results reported as number values (percentages), means (SDs), and medians (interquartile range), respectively. Given the retrospective nature of this study, to account for differing patient characteristics, logistic regression models were constructed using all available baseline information that related to the patient (age, sex, and chronic comorbidities) or hospital (location, level, admission
Key Points
Question What is the association between compensated hypercapnia and hypercapnic acidosis on hospital mortality in mechanically ventilated patients with acute cerebral injury?
Findings In this cross-sectional study including 30 742 patients with cerebral injury admitted to intensive care units in Australia and New Zealand, hospital mortality was higher in patients with hypercapnic acidosis compared with patients with compensated hypercapnia or normocapnia. In patients with hypercapnic acidosis, the adjusted odds ratio for hospital mortality increased with increasing partial pressure of carbon dioxide, while in patients with compensated hypercapnia, the adjusted odds did not change with increasing partial pressure of carbon dioxide.
Meaning
In mechanically ventilated patients with cerebral injury, hypercapnic acidosis is associated with increased mortality, and compensated hypercapnia appears to have no such association.
source, and time of admission) to identify each patient's probability (propensity) of presenting to the ICU with either hypercapnic acidosis or compensated hypercapnia (eTables 1 and 2intheSupplement). These models were constructed using both stepwise selection and backward elimination techniques, with only variables that were significant (P < .01) from both methods included. To investigate the independent effect of hypercapnia and hypercapnic acidosis on hospital mortality, hierarchical multivariable regression models were used using logistic regression for hospital death and Cox proportional hazards regression for time to death. These models adjusted for patient severity, propensity to be hypercapnic, propensity to be hypercapnic acidotic, baseline Glasgow Coma Scale (GCS) Score stratified into 3 groups (8) (9) (10) (11) (12) (13) (14) (15) , and year of admission, with patients nested in sites and sites treated as a random effect. Subgroup analysis relating to diagnosis, neurological severity (baseline GCS score), and operative status were performed using hierarchical multivariable logistic regression models. To determine whether the association between hypercapnic status and mortality differed according to the 3 diagnostic categories (diagnostic subgroup, neurological severity [baseline GCS score], or operative status), interaction terms with hypercapnic status were fitted. Duration of survivals have been presented as KaplanMeier curves with log-rank tests comparing equality of strata. Duration of stay variables (hospital and ICU length of stay) were log-transformed and analyzed using hierarchical mixed linear modeling, again adjusting for the covariates outlined here, with results presented as geometric means (95% CI). To account for survival bias, duration variables were further stratified by survival status. To facilitate a measure of patient severity independent of hypercapnia and neurological severity, each patient's predicted risk of death was calculated in accordance with the Australia and New Zealand Risk of Death methods, 14 with the components of pH, oxygen, and GCS score removed. Australia and New Zealand Risk of Death is an updated mortality prediction model specifically calibrated for use in Australia and New Zealand ICUs that has been derived from components of the Acute Physiology, Age, Chronic Health Evaluation II and III scoring systems, with additional diagnostic variables, and has been shown to have significantly better calibration and discrimination than Acute Physiology, Age, Chronic Health Evaluation III. To further ensure that our observed results were not driven by imbalances in patient severity, an additional matched sensitivity analysis was performed with patients from each of the 3 hypercapnic diagnostic categories matched for patient severity. Given the magnitude of the data set, to more closely align statistical and clinical significance, a 2-sided P value of .01 was used to indicate statistically significant results.
Results
A total of 30 742 patients were included in the study ( Figure 1) . A comparison of demographics, comorbidities, physiological and laboratory variables, and ICU admission diagnostic category data are presented in Table 1 . Patients with normocapnia and normal pH were younger and had lower comorbidities compared with other groups. Patients with compensated hypercapnia and hypercapnic acidosis differed from patients with normocapnia and normal pH levels in heart rate, blood pressure, and temperature, as well as renal and liver function test results during the first 24 hours of their ICU admission. Plasma glucose levels were higher in the hypercapnic acidosis group. Lower PaO 2 and higher PCO 2 levels were noted in patients with compensated hypercapnia and hypercapnic acidosis (Table 1) . Acute Physiology, Age, Chronic Health Evaluation III scores and customized Australia and New Zealand Risk of Death were lower in patients with normocapnia and normal pH levels (Table 1) . Unadjusted hospital mortality was higher, and discharge home was lower in patients with hypercapnic acidosis ( Table 2) . Patients with compensated hypercapnia had a higher discharge home rate compared with patients with hypercapnia acidosis or normocapnia and normal pH (Table 2) . Unadjusted hospital mortality rates were highest in patients with hypercapnic acidosis in all 3 diagnostic categories (eFigures 1-4 in the Supplement and Table 2 ). Hospital mortality increased in patients with hypercapnic acidosis with increasing PCO 2 (Figure 2 ). No such increased mortality was noted in patients with compensated hypercapnia. In patients with traumatic brain injury, lower hospital mortality was noted in patients with compensated hypercapnia (eFigure 4 in the Supplement and Table 2 ). Multivariable analysis using both logistic regression (hospital mortality) and Cox proportional hazards regression (time to death) confirmed patients with hypercapnic acidosis had an increased risk of death compared with patients with normocapnia and normal pH levels ( Table 3) . While this increased risk of death was evident across the 3 diagnostic categories, there was a statistically significant interaction between hypercapnic status and diagnosis indicating that the increase in risk of hospital mortality for patients with hypercapnic acidosis did differ according to diagnostic category, with the greatest risk for patients with cardiac arrest (odds ratio [OR], 1.51; 95% CI, 1.34-1.71); stroke (OR, 1.43; 95% CI, 1.27-1.6); and traumatic brain injury (OR, 1.22; 95% CI, 1.06-1.42; P <.001) ( Table 3) . Patients with compensated hypercapnia did not have an increased risk of hospital mortality compared with patients with normocapnia and normal pH levels (Table 3) . These findings were subsequently confirmed from sensitivity analysis matching patients for baseline severity eTable 3 in the Supplement.
In subgroup analysis based on baseline GCS score, patients with hypercapnic acidosis had consistent increased risk of hospital mortality for patients with cardiac arrest and stroke, with no significant evidence that the nature of the association between hypercapnic status and mortality differed according to baseline GCS score (eTable 4 in the Supplement). Patients with traumatic brain injury with hypercapnic acidosis had increased risk of hospital mortality (compared with normocapnia and normal pH levels) in patients with GCS score between 3-7; this was not the case for those with GCS score 8-12 and 13-15, with the interaction between hypercapnic status and GCS score not statistically significant (eTable 4 in the Supplement).
In further subgroups, analyses based on diagnostic subgroups (ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, subdural or extradural hemorrhage, isolated traumatic brain injury, and traumatic brain injury associated with other injuries), patients with hypercapnic acidosis consistently had an increase in risk (compared with normocapnia and normal pH levels) and there were no significant interactions among patients with stroke or patients with traumatic brain injury to indicate that the nature of the asso- ciation between hypercapnic status and mortality differed according to diagnostic subgroup (eTable 5 in the Supplement). Patients with compensated hypercapnia had no increased risk of hospital mortality compared with patients who had normocapnia and normal pH levels. Finally, in the subgroup analyses, based on the requirement of surgical intervention, patients with hypercapnic acidosis retained the highest risk of hospital mortality with no significant interactions between the requirement or nonrequirement of surgical intervention in patients with stroke or traumatic brain injury (eTable 6 in the Supplement).
The adjusted odds ratio of hospital mortality significantly differed between patients who had hypercapnic acidosis and compensated hypercapnia with increasing PCO 2 (Figure 2 ). In patients with hypercapnic acidosis, the adjusted odds ratio of hospital mortality increased with increasing PCO 2 . In patients with compensated hypercapnia, the adjusted odds of hospital mortality did not change with increasing PCO 2 (Figure 2 ).
Discussion
The main results of this study show that hospital mortality in patients with cerebral injury is higher in patients with hypercapnic acidosis compared with patients who had normocapnia or compensated hypercapnia. This increased mortality was consistent across all the 3 diagnostic categories and persisted after adjusting for the variables that principally contribute to hospital mortality. While mortality increased with increasing PCO 2 in patients with hypercapnic acidosis, it did not increase in patients with compensated hypercapnia.
The effects of hypercapnia in acute cerebral injury have been described in several studies. [15] [16] [17] [18] [19] [20] Most suggest normocapnia after cerebral injury is associated with better clinical outcomes, and hypocapnia and hypercapnia are associated with poor clinical outcomes. 2, 6, 15, 16, 19 However, in patients with cerebral injury secondary to cardiac arrest, there is some evidence to suggest that mild hypercapnia may be beneficial. Experimental studies have demonstrated mild to moderate hypercapnia to be neuroprotective after transient global cerebral ischemia reperfusion injury, while severe hypercapnia resulted in worsening of cerebral edema. 20 The study by Schneider et al 5 showed that in patients admitted to ICUs after cardiac arrest, presence of hypercapnia during the first 24 hours of ICU stay was associated with a greater likelihood of discharge home among survivors. 5 A pilot randomized clinical trial showed induction of mild hypercapnia after cardiac arrest reduced neuron-specific enolase, a biomarker of cerebral injury, compared with normocapnia. 17 Hypercapnia has been shown to increase cerebral blood flow in patients who were successfully resuscitated after cardiac arrest and in patients with subarachnoid hemorrhage. 9, 18, 21 Hypercapnia was also shown to have anticonvulsive 22 and antiinflammatory properties 23 that may be helpful to improve neurological recovery after cerebral injury. The results of our study show that compensated hypercapnia was not associated with an increase in adverse outcomes and that patient outcomes are comparable with those in patients with normocapnia and normal pH levels. However, in our study, we did not find improved outcomes in the compensated hypercapnia group compared with the normocapnic group. Further, prospective studies will be required to evaluate whether compensated hypercapnia may be beneficial in a subcategory of patients with cerebral injury. The effect of pH on clinical outcomes was predominantly studied in patients with out-of-hospital cardiac arrest.
11,24 A pH of at least 7.05 was found to be an independent predictor for a favorable outcome. 11 However, this study did not differentiate acidosis caused by carbon dioxide (hypercapnic acidosis) and metabolic acidosis. The study by Takaki et al 24 investigating the predictors of neurologic recovery in patients resuscitated after cardiac arrest found that blood pH had a stronger predictive power than CO 2 in patients after out-ofhospital cardiac arrest.
24
In patients with ischemic stroke, acidosis is common and has been demonstrated to be associated with toxic calcium influx into the cell and programmed cell death 25 and poorer outcomes. 12,13 Although our data do not provide information about the level of acidosis at the time of onset of the acute cerebral injury, prolonged acidosis into the first 24 hours of intensive care admission is likely to represent significant exposure to this mechanism for neuronal influx of calcium ions and higher levels of consequent injury caused by the excitotoxic action of glutamate release triggered by high intracellular levels of calcium 2. 26 Our data are also limited with respect to time at onset or pattern of brain injury for the patients with cardiac arrest and brain hemorrhage. However, although not reported in the literature, it is possible that similar mechanisms of secondary injury might be active in the cardiac arrest group experiencing prolonged periods of critically low brain blood flow and acidosis secondary to anaerobic metabolism and in the hemorrhage group in the context of mass effect or vasospasm causing focal ischemia.
Strengths
This study has several strengths. First, it involved more than 30 000 mechanically ventilated patients with cerebral injury from 167 ICUs (constituting about 80% of ICUs) in 2 countries, making its findings highly generalizable for all ICUs in Australia and New Zealand. This study specifically aimed to delineate the effects of hypercapnia with and without the effects of concurrent acidosis, which, to our knowledge, has not been studied in any earlier studies. It is likely that our findings have external validity in other developed countries with intensive care practices similar to Australia and New Zealand. To our knowledge, this is the largest study relating hypercapnic status to mortality published thus far, and the large sample size of our study enables identification of small but significant differences in outcomes. The Australian and New Zealand Intensive Care ICUs is robust and quality-controlled, with an established data dictionary to ensure uniformity and accuracy of the data collected.
Limitations
Our study is a retrospective study with inherent limitations. The worst value of Adult Patient Database PCO 2 and pH used in classifying patients was limited to the 24 hours after ICU admission. Thus, patients may have had more deranged blood gasses (abnormal PCO 2 and pH) prior to ICU admission or after 24 hours after ICU admission, and the absence of this data precluded evaluation of association of hypercapnic status before or after 24 hours of ICU admission on hospital mortality. However, most studies published thus far have also evaluated the association of hypercapnia on clinical outcomes using data during the first 24 hours of patient's hospital presentation. Our results are therefore comparable with existing literature. 2, 5, 11, 24, 29 Some patients presenting with compensated hypercapnia and hypercapnic acidosis may have had renal compensation prior to the ICU admission. From the data available, it was not possible to evaluate the proportion of patients with prior renal compensation before admission to ICU with cerebral injury or the etiology of hypercapnic acidosis that could have contributed to the increased mortality. We also did not have data on physiological indices, such as cerebral blood flow or intracranial pressure measurement, and neuroimaging data that could have helped in understanding the possible mechanisms in the increased mortality noted in patients with hypercapnic 
Conclusions
Hypercapnic acidosis was associated with increased risk of hospital mortality in patients with cerebral injury. Hypercapnia when compensated to normal pH during the first 24 hours of ICU admission may not be harmful in mechanically ventilated patients with cerebral injury. ** p value for interaction between diagnostic subgroup and hypercapnic group Stroke:0.24, Traumatic brain injury:0.81 *** all analyses are adjusted for GCS, patient severity (ANZROD with oxygen, pH and GCS components removed), propensity to present with hypercapnic acidosis, propensity to present with compensated hypercapnia and year of admission
